RCAG
ONC icon

Rehmann Capital Advisory Group’s BeOne Medicines Ltd ONC Stock Holding History

Rehmann Capital Advisory Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$3.06K Hold
25
– – ﹤0.01% 1327
2019
Q2 		$3.1K Hold
25
– – ﹤0.01% 1674
2019
Q1 		$3.3K Hold
25
– – ﹤0.01% 1631
2018
Q4 		$3.51K Buy
+25
New +$3.31K ﹤0.01% 1335

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Rehmann Capital Advisory Group's ONC Position: Q3 2019 in Review

Rehmann Capital Advisory Group held its BeOne Medicines Ltd (ONC) position steady in Q3 2019 at 25 shares worth $3.06K. The position accounts for ﹤0.01% of the portfolio, ranked #1327.

Rehmann Capital Advisory Group first reported a position in ONC in Q4 2018 and has held it in 4 quarters since. The position peaked at $3.51K in Q4 2018. 196 funds tracked by Wall St. Rank hold ONC as of Q3 2019.

  • Rehmann Capital Advisory Group held 25 shares of BeOne Medicines Ltd worth $3.06K as of Q3 2019.
  • Rehmann Capital Advisory Group left its BeOne Medicines Ltd share count unchanged in Q3 2019.
  • BeOne Medicines Ltd made up ﹤0.01% of Rehmann Capital Advisory Group's portfolio in Q3 2019, its #1327 holding.
  • Rehmann Capital Advisory Group first reported a position in BeOne Medicines Ltd in Q4 2018 and has held it in 4 quarters since.
  • Rehmann Capital Advisory Group's BeOne Medicines Ltd position peaked at $3.51K in Q4 2018.
  • 196 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.